JLL Taps McCready as Executive Director for Life Sciences Practice in Boston

Travis McCready

JLL has announced that Travis McCready has been appointed as Executive Director and National Practice Leader in the firm’s Life Sciences industry practice. Based in Boston, McCready will focus on partnering with local market teams to intensify JLL’s Life Sciences strategy across the U.S., while serving as an advisor to clients and providing the full spectrum of JLL’s Life Sciences real estate services.

With the worldwide prescription drug market expected to surpass $1 trillion by 2022, new life sciences hubs are emerging across the nation and looking to benefit from pandemic-related tailwinds. From already popular markets like Boston to rapidly expanding markets such as Seattle, McCready will help clients optimize their portfolios as they attempt to develop COVID-19-related vaccines.

“Beyond COVID-19, we can expect to see robust long-term fundamentals within life sciences continuing to draw in venture capital, private equity and corporate investors, driving growth and demand for life sciences real estate,” said Roger Humphrey, division president, industries at JLL. “Travis has a wealth of experience that will allow him to capitalize on the industry’s growth and translate it into business success.”

For comments, questions or concerns, please contact David Cohen